Palbociclib to reverse endocrine resistance in breast cancer: A TREnd in the right direction?

Amelia McCartney, Angelo Di Leo, Luca Malorni

Research output: Contribution to journalEditorialOtherpeer-review

Original languageEnglish
Pages (from-to)34031-34032
Number of pages2
JournalOncotarget
Volume9
Issue number75
DOIs
Publication statusPublished - 1 Sept 2018
Externally publishedYes

Keywords

  • Breast cancer
  • CDK4/6 inhibitors
  • Endocrine resistance
  • Metastatic
  • Palbociclib

Cite this